French pharamceutical giant Sanofi has confirmed plans to sell a controlling stake in its over-the-counter unit to a US ...

PARIS (Reuters) - The French government needs guarantees from drugmaker Sanofi that production of its popular Doliprane ...

French drugmaker Sanofi's confirmation that it will sell a controlling stake in its consumer health unit Opella to a US ...

Sanofi announced on Monday that it had entered into exclusive negotiations with US investment fund CD&R to sell it a majority ...

US private equity firm CD&R has agreed to French government demands seeking to protect jobs and investment in France.

Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, ...

The proposed sale turned into a real political issue because Opella's products include Doliprane, the best-selling medicine ...

In the French government issued a stern warning to Clayton, Dubilier & Rice (CD&R), an American private equity firm, ...

The sale of a French drugmaker to an American group is likely to now go ahead after French Economy Minister Antoine Armand ...

Politicians from across the political spectrum are up in arms over healthcare giant Sanofi's plans to sell France's ...

Unions in France are planning a walkout over the planned sale of the pharmaceutical company that makes popular painkiller ...

PARIS, Oct 14 (Reuters) - The French government needs guarantees from drugmaker Sanofi (SASY.PA), opens new tab that production of its popular Doliprane painkiller will stay in France to allow the ...